Clinical Characteristics of 16 Pediatric Patients With SCD and Stroke Who Discontinued Chronic Transfusions and Received Oral Hydroxyurea Therapy to Prevent Stroke Recurrence
Patient No. . | Hemoglobin Diagnosis . | Age at First Stroke (yr) . | Type of Stroke . | Transfusions . | Reasons to Stop Transfusions . | Age Transfusions Stopped (yr) . | |
---|---|---|---|---|---|---|---|
mo . | Type . | ||||||
1 | SS | 12.3 | R hemiplegia | 82 | S, E, P | AlloAb, AutoAb, Iron, NC | 19.1 |
2 | SS | 4.5 | R exotropia | 47 | S, E, P | AutoAb, NC | 8.4 |
3 | SS | 5.7 | L hemiplegia | 7 | S | AutoAb | 6.3 |
4 | SS | 7.7 | R hemiplegia, aphasia | 13 | S | 2nd stroke on transfusions | 8.8 |
5 | SS | 6.5 | L hemiplegia | 72 | S, E, P | AlloAb, AutoAb | 16.7 |
6 | SS | 6.4 | R hemiplegia, aphasia | 72 | S, E, P | Iron, NC | 12.3 |
7 | SS | 5.3 | R hemiplegia, aphasia | 37 | S, E | Iron | 8.4 |
8 | SS | 5.5 | Coma, seizures | 127 | S, E, P | Iron, DFO allergy | 16.1 |
9 | SS | 6.5 | R hemiplegia | 79 | S, P | Iron, NC | 13.1 |
10 | SS | 8.3 | R hand | 34 | S, E | Iron, NC | 11.2 |
11 | SS | 17.3 | L hemiplegia | 28 | S, E | NC | 19.7 |
12 | SS | 3.0 | L hemiplegia | 54 | S | Iron, DFO allergy | 7.6 |
13 | SS | 15.0 | R hemiplegia, aphasia | 39 | S, E | Iron, NC | 18.4 |
14 | SOArab | 1.1 | L hand | 22 | S | Iron | 2.9 |
15 | SS | 6.3 | R hemiplegia | 54 | S, E, P | Iron | 10.7 |
16 | SS | 2.7 | L hand | 127 | S | Iron | 13.3 |
Patient No. . | Hemoglobin Diagnosis . | Age at First Stroke (yr) . | Type of Stroke . | Transfusions . | Reasons to Stop Transfusions . | Age Transfusions Stopped (yr) . | |
---|---|---|---|---|---|---|---|
mo . | Type . | ||||||
1 | SS | 12.3 | R hemiplegia | 82 | S, E, P | AlloAb, AutoAb, Iron, NC | 19.1 |
2 | SS | 4.5 | R exotropia | 47 | S, E, P | AutoAb, NC | 8.4 |
3 | SS | 5.7 | L hemiplegia | 7 | S | AutoAb | 6.3 |
4 | SS | 7.7 | R hemiplegia, aphasia | 13 | S | 2nd stroke on transfusions | 8.8 |
5 | SS | 6.5 | L hemiplegia | 72 | S, E, P | AlloAb, AutoAb | 16.7 |
6 | SS | 6.4 | R hemiplegia, aphasia | 72 | S, E, P | Iron, NC | 12.3 |
7 | SS | 5.3 | R hemiplegia, aphasia | 37 | S, E | Iron | 8.4 |
8 | SS | 5.5 | Coma, seizures | 127 | S, E, P | Iron, DFO allergy | 16.1 |
9 | SS | 6.5 | R hemiplegia | 79 | S, P | Iron, NC | 13.1 |
10 | SS | 8.3 | R hand | 34 | S, E | Iron, NC | 11.2 |
11 | SS | 17.3 | L hemiplegia | 28 | S, E | NC | 19.7 |
12 | SS | 3.0 | L hemiplegia | 54 | S | Iron, DFO allergy | 7.6 |
13 | SS | 15.0 | R hemiplegia, aphasia | 39 | S, E | Iron, NC | 18.4 |
14 | SOArab | 1.1 | L hand | 22 | S | Iron | 2.9 |
15 | SS | 6.3 | R hemiplegia | 54 | S, E, P | Iron | 10.7 |
16 | SS | 2.7 | L hand | 127 | S | Iron | 13.3 |
Abbreviations: R, right; L, left; S, simple transfusions; E, erythrocytapheresis; P, partial exchange transfusions; AlloAb, erythrocyte alloantibodies; AutoAb, erythrocyte autoantibodies; DFO, deferoxamine; NC, noncompliance; SS, homozygous sickle cell anemia; SOArab, heterozygous HbS and HbOArab.